BALTIMORE and SHANGHAI, June 11, 2018  /PRNewswire/ -- Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of deep learning for target identification, drug discovery and aging research, announces the completion of a strategic...